Skip to Content
Interactive Textbook on Clinical Symptom Research Logo


Home Button

Oral Mucositis
Author Bios
Introduction
Etiology of Oral Mucositis
Prevalence
Diagnosis
Treatment
Biological Mechanisms of Mucositis
Currently selected section: Assessment Scale
Clinical Trial Design
Population Selection and Randomization
Data Collection and Assessment Measures
Quality Control Techniques
Anaysis and Presentation
Conclusion


Chapter 17: Oral Mucositis: Mucositis Assessment Scale
        

When the OMAS scale was compared to the NCI scale in a test of accuracy, the measures of symptoms were well correlated. In fact, the OMAS and NCI scores were virtually superimposable. The data as a whole indicate that both the mean mucositis score and the extent of severe mucositis score, calculated over time either as the area under the curve or as the average of the 3 highest values, produced scores that were reproducible and responsive to change. This scale, however, is not sensitive to low grades of oral mucositis. This finding would not appear to impact on the scale's utility as applied to clinical trials because, generally, efficacy of a study drug is measured by changes in clinically significant mucositis (Sonis et al., 1999).

The OMAS scale was tested for ease of use by investigators, tolerability by patients, interobserver reproducibility, and correlation between investigators. Investigators reported that the scale was used easily and that evaluations were completed in less than five minutes. However, the repetitive examinations proved to be difficult for patients with severe mucositis. Investigators showed high correlation in scores over time. Interobserver reproducibility demonstrated acceptable correlations. In addition, future use of this scale may not need concomitant symptomatic measurements by VAS and questionnaires because there was a strong correlation between objective findings and pain, difficulty swallowing, and eating (Sonis et al., 1999).

The OMAS scale is one of a few scales created as a research tool, but regardless of which scale is used for assessing oral mucositis, training the research team is essential in obtaining reliable data. Training sessions to master the understanding of the implemented scales and to calibrate scores among various raters are essential for producing accurate data. The FDA may require the simultaneous use of at least two scales to ensure consistency, which may be confusing if raters are not trained (Sonis et al., 1999).

Despite attempts to find the perfect mucositis scale, researchers have not reached a consensus regarding an easily-used, easily interpreted, accurate, and reproducible scoring system.


Page 9 of 21
Previous Page